These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 12787233)
21. [Discrimination perceived by people with a diagnosis of schizophrenic disorders. INternational study of DIscrimination and stiGma Outcomes (INDIGO): French results]. Daumerie N; Vasseur Bacle S; Giordana JY; Bourdais Mannone C; Caria A; Roelandt JL Encephale; 2012 Jun; 38(3):224-31. PubMed ID: 22726410 [TBL] [Abstract][Full Text] [Related]
22. Scleroderma patient perspectives on social support from close social relationships. Milette K; Thombs BD; Dewez S; Körner A; Peláez S Disabil Rehabil; 2020 Jun; 42(11):1588-1598. PubMed ID: 30761932 [No Abstract] [Full Text] [Related]
23. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease. Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084 [TBL] [Abstract][Full Text] [Related]
24. Patients with scleroderma. Crossfield T Nursing (Lond); 1990 May 10-23; 4(10):19-20. PubMed ID: 2366983 [No Abstract] [Full Text] [Related]
25. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review. Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039 [TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life, optimism, and coping strategies in persons suffering from localized scleroderma. Szramka-Pawlak B; Dańczak-Pazdrowska A; Rzepa T; Szewczyk A; Sadowska-Przytocka A; Żaba R Psychol Health Med; 2013; 18(6):654-63. PubMed ID: 23398519 [TBL] [Abstract][Full Text] [Related]
27. The experience of emotional distress among women with scleroderma. Newton EG; Thombs BD; Groleau D Qual Health Res; 2012 Sep; 22(9):1195-206. PubMed ID: 22875832 [TBL] [Abstract][Full Text] [Related]
28. Prospective study to evaluate the clinical and radiological outcome of patients with scleroderma of the face. Careta MF; Leite Cda C; Cresta F; Albino J; Tsunami M; Romiti R Autoimmun Rev; 2013 Sep; 12(11):1064-9. PubMed ID: 23791631 [TBL] [Abstract][Full Text] [Related]
29. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM; Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489 [TBL] [Abstract][Full Text] [Related]
30. Psychologic factors in scleroderma. Haythornthwaite JA; Heinberg LJ; McGuire L Rheum Dis Clin North Am; 2003 May; 29(2):427-39. PubMed ID: 12841303 [TBL] [Abstract][Full Text] [Related]
31. Living with scleroderma: patients' perspectives, a phenomenological study. Cinar FI; Unver V; Yilmaz S; Cinar M; Yilmaz F; Simsek I; Erdem H; Pay S; Dinc A Rheumatol Int; 2012 Nov; 32(11):3573-9. PubMed ID: 22090008 [TBL] [Abstract][Full Text] [Related]
32. Patients' Perspectives and Experiences Living with Systemic Sclerosis: A Systematic Review and Thematic Synthesis of Qualitative Studies. Nakayama A; Tunnicliffe DJ; Thakkar V; Singh-Grewal D; O'Neill S; Craig JC; Tong A J Rheumatol; 2016 Jul; 43(7):1363-75. PubMed ID: 27134259 [TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. Del Rosso A; Boldrini M; D'Agostino D; Placidi GP; Scarpato A; Pignone A; Generini S; Konttinen Y; Zoppi M; Vlak T; Placidi G; Matucci-Cerinic M Arthritis Rheum; 2004 Jun; 51(3):475-81. PubMed ID: 15188336 [TBL] [Abstract][Full Text] [Related]
34. "I'm still dad": The Impact of Scleroderma on being a Father. Poole JL; Haygood D; Mendelson C Occup Ther Health Care; 2018 Jan; 32(1):1-13. PubMed ID: 29351518 [TBL] [Abstract][Full Text] [Related]
35. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]. Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902 [TBL] [Abstract][Full Text] [Related]
36. Exercise habits and factors associated with exercise in systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study. Azar M; Rice DB; Kwakkenbos L; Carrier ME; Shrier I; Bartlett SJ; Hudson M; Mouthon L; Poiraudeau S; van den Ende CHM; Johnson SR; Rodriguez Reyna TS; Schouffoer AA; Welling J; Thombs BD; Disabil Rehabil; 2018 Aug; 40(17):1997-2003. PubMed ID: 28478701 [TBL] [Abstract][Full Text] [Related]
37. Cognitive difficulties in people with systemic sclerosis: a qualitative study. Chen YT; Lescoat A; Devine A; Khanna D; Murphy SL Rheumatology (Oxford); 2022 Aug; 61(9):3754-3765. PubMed ID: 35015836 [TBL] [Abstract][Full Text] [Related]
38. Experiencing work as a daily challenge: the case of scleroderma. Mendelson C; Poole JL; Allaire S Work; 2013; 44(4):405-13. PubMed ID: 22927612 [TBL] [Abstract][Full Text] [Related]
39. Become your own advocate: advice from women living with scleroderma. Mendelson C; Poole JL Disabil Rehabil; 2007 Oct; 29(19):1492-501. PubMed ID: 17852224 [TBL] [Abstract][Full Text] [Related]
40. Disease and symptom burden in systemic sclerosis: a patient perspective. Suarez-Almazor ME; Kallen MA; Roundtree AK; Mayes M J Rheumatol; 2007 Aug; 34(8):1718-26. PubMed ID: 17611983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]